| 1. | Preparation of gliclazide - hydroxypropyl - - cyclodextrin inclusion complexes
环糊精包合物的制备 |
| 2. | Determination of gliclazide tablets by single sweep oscillopolarography
格列齐特片的单扫描示波极谱法测定 |
| 3. | Effects of slow - release gliclazide on vascular function in treatment of chinese patients with type 2 diabetes mellitus
格列齐特缓释片对2型糖尿病患者血管功能的影响 |
| 4. | Conclusions : treatment with glibenclamide could be associated with higher mortality for cardiovascular diseases and malignancies , in comparison with gliclazide
结论：与格列齐物相比，服用格列苯脲与更高的心血管疾病和恶性肿瘤相关死亡率有关。 |
| 5. | Background : aim of the present study is the comparison of all - cause , cardiovascular and non - cardiovascular mortality , and cardiac morbidity , between patients treated with glibenclamide and gliclazide
研究背景：现状研究的目的是比较服用格列苯脲和格列齐特患者之间全造成的心血管与非心血管病死亡率、心血管病发病率。 |
| 6. | Methods : a retrospectie obserational cohort study was performed on a consecutie series of 568 outpatients ( 282 women , 286 men ) with type 2 diabetes treated with either glibenclamide ( n = 378 ) or gliclazide ( n = 190 )
方法：回顾性观察队列研究连续门诊2型糖尿病患者568例（女282例，男286例） ，服格列苯脲组378例，服格列齐特190例。 |
| 7. | Methods : a retrospective observational cohort study was performed on a consecutive series of 568 outpatients ( 282 women , 286 men ) with type 2 diabetes treated with either glibenclamide ( n = 378 ) or gliclazide ( n = 190 )
方法：回顾性观察队列研究连续门诊2型糖尿病患者568例（女282例，男286例） ，服格列苯脲组378例，服格列齐特190例。 |
| 8. | The three patients , two women aged 41 and 86 and a 76 - year - old man , developed symptoms of attack of low blood glucose after taking the drug labelled as " simethicone " , which was subsequently found to be gliclazide ( a drug for diabetes ) during laboratory testing by the hospital authority
三名病人为一名76岁男子及两名年龄41及86岁的女子，他们服食" simethicone "药物后，出现血糖低的病徵。医院管理局的化验室其后发现该药物事实为一种糖尿药gliclazide 。 |
